214 related articles for article (PubMed ID: 11071382)
1. Differential effect of FBN1 mutations on in vitro proteolysis of recombinant fibrillin-1 fragments.
Booms P; Tiecke F; Rosenberg T; Hagemeier C; Robinson PN
Hum Genet; 2000 Sep; 107(3):216-24. PubMed ID: 11071382
[TBL] [Abstract][Full Text] [Related]
2. The roles of two novel FBN1 gene mutations in the genotype-phenotype correlations of Marfan syndrome and ectopia lentis patients with marfanoid habitus.
Li D; Yu J; Gu F; Pang X; Ma X; Li R; Liu N; Ma X
Genet Test; 2008 Jun; 12(2):325-30. PubMed ID: 18471089
[TBL] [Abstract][Full Text] [Related]
3. Molecular effects of homocysteine on cbEGF domain structure: insights into the pathogenesis of homocystinuria.
Hutchinson S; Aplin RT; Webb H; Kettle S; Timmermans J; Boers GH; Handford PA
J Mol Biol; 2005 Feb; 346(3):833-44. PubMed ID: 15713466
[TBL] [Abstract][Full Text] [Related]
4. Identification of a novel FBN1 gene mutation in a large Pakistani family with Marfan syndrome.
Micheal S; Khan MI; Akhtar F; Weiss MM; Islam F; Ali M; Qamar R; Maugeri A; den Hollander AI
Mol Vis; 2012; 18():1918-26. PubMed ID: 22876116
[TBL] [Abstract][Full Text] [Related]
5. Effects of the N2144S mutation on backbone dynamics of a TB-cbEGF domain pair from human fibrillin-1.
Yuan X; Werner JM; Lack J; Knott V; Handford PA; Campbell ID; Downing AK
J Mol Biol; 2002 Feb; 316(1):113-25. PubMed ID: 11829507
[TBL] [Abstract][Full Text] [Related]
6. Molecular effects of calcium binding mutations in Marfan syndrome depend on domain context.
McGettrick AJ; Knott V; Willis A; Handford PA
Hum Mol Genet; 2000 Aug; 9(13):1987-94. PubMed ID: 10942427
[TBL] [Abstract][Full Text] [Related]
7. Mutations in the fibrillin gene responsible for dominant ectopia lentis and neonatal Marfan syndrome.
Kainulainen K; Karttunen L; Puhakka L; Sakai L; Peltonen L
Nat Genet; 1994 Jan; 6(1):64-9. PubMed ID: 8136837
[TBL] [Abstract][Full Text] [Related]
8. Genotype and phenotype analysis of 171 patients referred for molecular study of the fibrillin-1 gene FBN1 because of suspected Marfan syndrome.
Loeys B; Nuytinck L; Delvaux I; De Bie S; De Paepe A
Arch Intern Med; 2001 Nov; 161(20):2447-54. PubMed ID: 11700157
[TBL] [Abstract][Full Text] [Related]
9. Engineered mutations in fibrillin-1 leading to Marfan syndrome act at the protein, cellular and organismal levels.
Zeyer KA; Reinhardt DP
Mutat Res Rev Mutat Res; 2015; 765():7-18. PubMed ID: 26281765
[TBL] [Abstract][Full Text] [Related]
10. RGD-containing fibrillin-1 fragments upregulate matrix metalloproteinase expression in cell culture: a potential factor in the pathogenesis of the Marfan syndrome.
Booms P; Pregla R; Ney A; Barthel F; Reinhardt DP; Pletschacher A; Mundlos S; Robinson PN
Hum Genet; 2005 Jan; 116(1-2):51-61. PubMed ID: 15517394
[TBL] [Abstract][Full Text] [Related]
11. A novel mutation of the fibrillin gene causing ectopia lentis.
Lönnqvist L; Child A; Kainulainen K; Davidson R; Puhakka L; Peltonen L
Genomics; 1994 Feb; 19(3):573-6. PubMed ID: 8188302
[TBL] [Abstract][Full Text] [Related]
12. Mutations of FBN1 and genotype-phenotype correlations in Marfan syndrome and related fibrillinopathies.
Robinson PN; Booms P; Katzke S; Ladewig M; Neumann L; Palz M; Pregla R; Tiecke F; Rosenberg T
Hum Mutat; 2002 Sep; 20(3):153-61. PubMed ID: 12203987
[TBL] [Abstract][Full Text] [Related]
13. Mutations in calcium-binding epidermal growth factor modules render fibrillin-1 susceptible to proteolysis. A potential disease-causing mechanism in Marfan syndrome.
Reinhardt DP; Ono RN; Notbohm H; Müller PK; Bächinger HP; Sakai LY
J Biol Chem; 2000 Apr; 275(16):12339-45. PubMed ID: 10766875
[TBL] [Abstract][Full Text] [Related]
14. FBN1 mutation screening of patients with Marfan syndrome and related disorders: detection of 46 novel FBN1 mutations.
Attanasio M; Lapini I; Evangelisti L; Lucarini L; Giusti B; Porciani M; Fattori R; Anichini C; Abbate R; Gensini G; Pepe G
Clin Genet; 2008 Jul; 74(1):39-46. PubMed ID: 18435798
[TBL] [Abstract][Full Text] [Related]
15. The molecular pathogenesis of the Marfan syndrome.
Robinson PN; Booms P
Cell Mol Life Sci; 2001 Oct; 58(11):1698-707. PubMed ID: 11706995
[TBL] [Abstract][Full Text] [Related]
16. Cysteine substitutions in epidermal growth factor-like domains of fibrillin-1: distinct effects on biochemical and clinical phenotypes.
Schrijver I; Liu W; Brenn T; Furthmayr H; Francke U
Am J Hum Genet; 1999 Oct; 65(4):1007-20. PubMed ID: 10486319
[TBL] [Abstract][Full Text] [Related]
17. Clustering of mutations associated with mild Marfan-like phenotypes in the 3' region of FBN1 suggests a potential genotype-phenotype correlation.
Palz M; Tiecke F; Booms P; Göldner B; Rosenberg T; Fuchs J; Skovby F; Schumacher H; Kaufmann UC; von Kodolitsch Y; Nienaber CA; Leitner C; Katzke S; Vetter B; Hagemeier C; Robinson PN
Am J Med Genet; 2000 Mar; 91(3):212-21. PubMed ID: 10756346
[TBL] [Abstract][Full Text] [Related]
18. Fibrillin-1 (FBN1) gene frameshift mutations in Marfan patients: genotype-phenotype correlation.
Pepe G; Giusti B; Evangelisti L; Porciani MC; Brunelli T; Giurlani L; Attanasio M; Fattori R; Bagni C; Comeglio P; Abbate R; Gensini GF
Clin Genet; 2001 Jun; 59(6):444-50. PubMed ID: 11453977
[TBL] [Abstract][Full Text] [Related]
19. Identification of 29 novel and nine recurrent fibrillin-1 (FBN1) mutations and genotype-phenotype correlations in 76 patients with Marfan syndrome.
Rommel K; Karck M; Haverich A; von Kodolitsch Y; Rybczynski M; Müller G; Singh KK; Schmidtke J; Arslan-Kirchner M
Hum Mutat; 2005 Dec; 26(6):529-39. PubMed ID: 16220557
[TBL] [Abstract][Full Text] [Related]
20. A novel de novo mutation in exon 14 of the fibrillin-1 gene associated with delayed secretion of fibrillin in a patient with a mild Marfan phenotype.
Booms P; Withers AP; Boxer M; Kaufmann UC; Hagemeier C; Vetter U; Robinson PN
Hum Genet; 1997 Aug; 100(2):195-200. PubMed ID: 9254848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
